"African governments invest less on HIV/Aids than expected. For the continent as a whole, about five per cent of health budgets are allocated to the scourge, despite its causing a median of more than seven per cent of the overall burden of disease across countries," stated part of a brief posted on the agency’s website early this week.
The brief, titled Aids Dependency Crisis: Sourcing African Solutions, reveals that two-thirds of all HIV and Aids expenditure in Africa comes from external sources.
The agency also noted that procurement of anti-retroviral drugs was highly dependent on external funding. In 27 countries for which accurate data was available, 84 per cent of expenditure for ARV therapy originated from international sources.
"Investing in local manufacturing and simplifying market access to drugs across the continent will boost the economy, reduce costs and ultimately save lives and money,"